Biohaven (BHVN) Enterprise Value (2021 - 2026)

Biohaven has disclosed Enterprise Value across 6 years of filings, most recently posting -$347.8 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$347.8 million, down 7.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$347.8 million (down 7.77% YoY), and the FY2025 annual result was -$319.1 million, up 34.33% from the prior year.
• Enterprise Value came in at -$347.8 million for Q1 2026 at Biohaven, down from -$319.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$23.2 million in Q2 2022 to a low of -$486.0 million in Q4 2024.
• The 5-year median for Enterprise Value is -$322.7 million (2025), against an average of -$295.2 million.
• Peak annual rise in Enterprise Value reached 85.99% in 2022, while the deepest fall reached 2798.06% in 2022.
• Biohaven's Enterprise Value stood at -$465.3 million in 2022, then climbed by 17.95% to -$381.8 million in 2023, then retreated by 27.28% to -$486.0 million in 2024, then soared by 34.33% to -$319.1 million in 2025, then declined by 8.99% to -$347.8 million in 2026.
• The last three Enterprise Value figures came in at -$347.8 million (Q1 2026), -$319.1 million (Q4 2025), and -$260.2 million (Q3 2025), per Business Quant data.